Lucinda Quan

Lucinda Quan serves as the Chief Operating Officer and Co-Founder of TCG Labs-Soleil since November 2023. Prior to this role, Lucinda co-founded Aligos Therapeutics in April 2018, where responsibilities included serving as an Advisor and holding the position of EVP, Chief Business Officer, and General Counsel. Lucinda's previous experience includes serving as Executive Director for Transactions, Business Development & Licensing at Merck from January 2016 to April 2018 and as Vice President of Legal Affairs at Alios BioPharma until its acquisition by Johnson & Johnson in October 2014. Additionally, Lucinda held the role of Vice President, Legal Affairs and Associate General Counsel at InterMune until its acquisition by Roche in September 2014. Early career milestones include positions at Clifford Chance US LLP, Brobeck, Phleger & Harrison, and Luce, Forward, Hamilton & Scripps LLP. Lucinda holds a B.A. in Business Economics and a J.D. from the University of California, Los Angeles.